1 withdrawn. 1 Phase 3.
| Phase | Trials | Status |
|---|---|---|
| Phase 3 | 1 | Withdrawn 1 |
Follow Eye Hemorrhage: new trials by email Literature Review of Eye Hemorrhage trials Research Report on Eye Hemorrhage
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| A Study of the Safety, Tolerability, and Efficacy of IVT Pre-op 0.3mg Pegaptanib Sodium Versus Sham, for Management of Tractional Retinal Detachment and Vitreous Hemorrhage With Proliferative Diabetic Retinopathy Macugen, Sham - Proliferative Diabetic Retinopathy | Phase 3 | Withdrawn | Greater Houston Retina Research | 2012-04-01 | 2014-03-05 |
Eye Diseases (1) · Hemorrhage (1) · Pathologic Processes (1) · Pathological Conditions, Signs and Symptoms (1)
pegaptanib (1) · salicylhydroxamic acid (1)
Greater Houston Retina Research (1)
United States (1)